Sorrento Therapeutics has been granted a patent for an implantable delivery device with nano and microstructures to deliver bioactive agents without triggering an immune response. The device’s unique nanotopography allows for precise and efficient delivery to subjects in need. GlobalData’s report on Sorrento Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Sorrento Therapeutics, Personalized cancer vaccines was a key innovation area identified from patents. Sorrento Therapeutics's grant share as of February 2024 was 57%. Grant share is based on the ratio of number of grants to total number of patents.
Implantable device for delivering bioactive agents without immune response
A newly granted patent (Publication Number: US11925712B2) discloses a fully implantable delivery device designed for administering bioactive agents to a subject. The device features a wall with a surface that includes a unique combination of nanostructures and microstructures arranged in a fractal dimension greater than about 1. These structures are crucial for efficient delivery of the bioactive agent to the target site within the subject's body.
Furthermore, the patent details various configurations of the fully implantable delivery device, highlighting specific dimensions and spacing requirements for the nanostructures and microstructures. The device is equipped with a reservoir containing the bioactive agent, ensuring sustained release and interaction with the surrounding tissue near the implantation site. With features like an effective shear modulus range and aspect ratios specified for the structures, the device aims to optimize the delivery process and enhance the therapeutic outcomes for the subject.
To know more about GlobalData’s detailed insights on Sorrento Therapeutics, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
